No Data
J.P. Morgan Remains a Buy on Daiichi Sankyo Company (DSKYF)
Daichii Sankyo (DSNKY.US) ADC cancer new drug has been approved for clinical use in China.
The ADC cancer new drug from Daiichi Sankyo (DSNKY.US) has been approved for clinical use in China.
The Nikkei average rose by 286 points, continuing to rise, showing steady progress, but its upward momentum weakened toward the end of trading on the 6th.
On the 6th, the Nikkei average stock price rose by 286.69 yen compared to the previous day, reaching 37,704.93 yen, while the TOPIX (Tokyo Stock Price Index) also rose by 33.20 points to 2,751.41 points, continuing its upward trend. On the 5th, in the US stock market, it was revealed that tariffs on imported goods from Canada and Mexico would be suspended for one month for automobile-related items, easing excessive concerns about the US economy, leading to a rebound in both the NY Dow and Nasdaq Composite Index for the first time in three days. Japanese stocks also received a boost, with buying observed across a wide range of stocks.
Sakata Inks, artience ETC (additional) Rating
Upgraded - Bullish Code Stock Name Securities Company Previous After ----------------------------------------------------------- <2269> Meiji HD Morgan Stanley "Underweight" "Equal Weight" <2768> Sojitz Mizuho "Hold" "Buy" <3110> Nitto Boseki Daiwa "3" "2" <7011> Mitsubishi Heavy GS "Hold" "Buy" Downgraded - Bearish Code Stock Name Securities Company Previous After ---------------
The Nikkei Average is up about 380 yen, with Nippon Steel, Okuma, Mitsubishi Heavy Industries, ETC among the top gainers.
On the 6th at 11:02 AM, the Nikkei average stock price hovered around 37,800 yen, up approximately 380 yen from the previous day. At 9:42 AM, it reached 37,874.38 yen, up 456.14 yen. On the 5th, the U.S. government announced that it would impose a 25% tariff on imports from Canada and Mexico, but would give a one-month grace period for the automobile sector. In the U.S. stock market, excessive caution regarding the U.S. economy subsided, and both the Dow Inc and Nasdaq composite index rebounded for the first time in three days. Japanese stocks also followed that movement.
Daiichi Sankyo and AstraZeneca's Enhertu Shows OS Improvements in Phase III Trial